6 campaigns that use hearts to touch ours
Tara Powers is VP, creative director at Elevate Healthcare.
Heart Failure
Novartis awards two for their heart hacks at TechCrunch event
Two makers of health apps walked away with the top prizes and access to more from the drugmaker.
Five things for pharma marketers to know: Wednesday, January 3, 2018
Utah Senator who backed Orphan Drug Act will not seek reelection; medicines more expensive in 2018; Spark’s genetic therapy for rare blindness costs $850,000
Five things for pharma marketers to know: Thursday, April 27, 2017
Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients
Five things for pharma marketers to know: Wednesday, March 22, 2017
Novartis’ heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron’s Xadago for PD
When it comes to PCSK9s, payers resisted — and sales flopped
The first two PCSK9s landed with a thud. What does their disappointing launch say about the need for marketers of CV drugs to get their pricing houses in order?
Five things for pharma marketers to know: Tuesday, October 25, 2016
Novartis’ Entresto and Cosentyx miss sales forecasts; faith-based investor group urges pricing transparency; Amgen invests in digital health
Novartis ups marketing investment in Entresto, by $200 million
One oft-cited challenge to Entresto’s adoption has been prior authorization requirements.
Practice Fusion founder launches heart-monitoring wearable
The new company, iBeat, plans to market a wearable device that can detect the symptoms of cardiac arrest and heart attacks.
Five things for pharma marketers to know: Thursday, May 19, 2016
Novartis plans new trials for Entresto; U.S. spending on mental health topped $201 billion in 2013; the FDA approves Roche’s immunotherapy drug
